DOCSLIB.ORG

Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Dry Mouth / Xerostomia

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Dry Mouth / Xerostomia Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Dry Mouth / Xerostomia Chemical Activity Count (+)-CATECHIN 2 (+)-EPIPINORESINOL 1 (-)-ANABASINE 1 (-)-EPICATECHIN 2 (-)-EPIGALLOCATECHIN 2 (-)-EPIGALLOCATECHIN-GALLATE 2 (Z)-1,3-BIS(4-HYDROXYPHENYL)-1,4-PENTADIENE 1 1,8-CINEOLE 2 10-METHOXYCAMPTOTHECIN 1 16-HYDROXY-4,4,10,13-TETRAMETHYL-17-(4-METHYL-PENTYL)-HEXADECAHYDRO- 1 CYCLOPENTA[A]PHENANTHREN-3-ONE 2,3-DIHYDROXYBENZOIC-ACID 1 3'-O-METHYL-CATECHIN 1 3-ACETYLACONITINE 1 3-O-METHYL-(+)-CATECHIN 1 4-O-METHYL-GLUCURONOXYLAN 1 5,7-DIHYDROXY-2-METHYLCHROMONE-8-C-BETA-GLUCOPYRANOSIDE 1 5-HYDROXYTRYPTAMINE 1 5-HYDROXYTRYPTOPHAN 1 6-METHOXY-BENZOLINONE 1 ACEMANNAN 1 ACETYL-CHOLINE 1 ACONITINE 2 ADENOSINE 2 AFFINISINE 1 AGRIMONIIN 1 ALANTOLACTONE 2 ALKANNIN 1 Chemical Activity Count ALLANTOIN 1 ALLICIN 2 ALLIIN 2 ALLOISOPTEROPODINE 1 ALLOPTEROPODINE 1 ALLOPURINOL 1 ALPHA-LINOLENIC-ACID 1 ALPHA-TERPINEOL 1 ALPHA-TOCOPHEROL 2 AMAROGENTIN 1 AMELLIN 1 ANABASINE 1 ANDROMEDOTOXIN 1 ANETHOLE 1 ANTHOCYANIDINS 1 ANTHOCYANINS 1 ANTHOCYANOSIDE 1 APIGENIN 1 APOMORPHINE 1 ARABINO-3,6-GALACTAN-PROTEIN 1 ARABINOGALACTAN 1 ARACHIDONIC-ACID 1 ARCTIGENIN 2 ARECOLINE 1 ARGLABRIN 1 ARISTOLOCHIC-ACID 1 ARISTOLOCHIC-ACID-I 1 2 Chemical Activity Count ARMILLARIEN-A 1 ARTEMISININ 1 ASCORBIC-ACID 4 ASTRAGALAN-I 1 ASTRAGALAN-II 1 ASTRAGALAN-III 1 ASTRAGALIN 1 AURICULOSIDE 1 BAICALEIN 1 BAICALIN 1 BAKUCHIOL 1 BENZALDEHYDE 1 BERBAMINE 1 BERBERASTINE 3 BERBERINE 3 BERBERINE-CHLORIDE 1 BERBERINE-IODIDE 1 BERBERINE-SULFATE 1 BETA-AMYRIN-PALMITATE 1 BETA-ASARONE 1 BETA-CAROTENE 1 BETA-IONONE 1 BIFLORIN 1 BILOBALIDE 1 BOLDINE 2 BROMELAIN 1 BULBOCAPNINE 2 3 Chemical Activity Count BUPLUERAN-2IIC 1 CAFFEIC-ACID 3 CAFFEINE 1 CALCIUM 3 CALEBIN-A 1 CAPILLIN 1 CAPSAICIN 1 CARRAGEENAN 1 CARVACROL 1 CARYOPHYLLENE 1 CASTANOSPERMINE 1 CATECHIN 3 CAVININE 1 CEPHARANTHINE 1 CHARANTIN 1 CHELERYTHRINE 1 CHICORIC-ACID 1 CHIKUSETSUSAPONIN 1 CHIMAPHYLIN 1 CHLOROGENIC-ACID 2 CHOLINE 1 CHROMIUM 2 CHRYSIN 1 CICHORIC-ACID 1 CINNAMAN-AX 1 CIS-ISOASARONE 1 CLEISTANTHIN 1 4 Chemical Activity Count COPPER 2 CORDIOFOLISIDE-A 1 CORDIOL 1 CORDIOSIDE 1 CORONARIDINE 1 COUMARIN 1 COUMESTROL 1 CROCETIN 1 CROCIN 1 CURCULIGOSIDE 1 CURCUMIN 2 CYANIDIN-3-O-GLUCOSIDE 1 CYCLOALLIIN 1 CYNANCHOSIDE 1 DAIDZEIN 1 DAPHNETIN 1 DELTA-CADINENE 1 DENDROBINE 1 DIALLYL-DISULFIDE 1 DIALLYL-THIOSULFONATE 1 DIAZEPAM 1 DICHOTOSIN 1 DIFFUTIN 1 DIHYDROKAWAIN 1 DIHYDROMETHYSTICIN 1 DIKETOCORIOLIN-B 1 DIOSPYRIN 1 5 Chemical Activity Count DIPHENYLAMINE 1 DOLICHODIAL 1 ECHINACEIN 1 ECHINACOSIDE 1 ELEMICIN 1 ELEUTHEROSIDES 1 ELLAGIC-ACID 2 ELLAGITANNIN 1 EMETINE 1 EMODIN 2 EMODIN-BIANTHRONE 1 EPICATECHIN 1 EPICATECHIN-GALLATE 2 ESTROGENS 1 ETHYL-ACRYLATE 1 EUCALYPTONE 1 EUCOMMIN-A 1 EUFOLIATIN 1 EUFOLIATORIN 1 EUPAHYSSOPIN 1 EUPALINE 1 EUPATORIN 1 EUPERFOLIN 1 EUPERFOLITIN 1 FERULIC-ACID 1 FIBER 1 FLAVONE 1 6 Chemical Activity Count FLUORIDE 1 FOLACIN 2 FOLIC-ACID 3 FORSKOLIN 1 FRUCTOSE 1 FUCANS 1 FUCOGALACTOXYLOGLUCAN 1 FUCOIDAN 1 GABA 1 GALEGINE 1 GALLIC-ACID 2 GAMMA-AMINOBUTYRIC-ACID 1 GAMMA-LINOLENIC-ACID 1 GELSEMICINE 1 GENISTEIN 2 GERANIOL 1 GINKGOLIDE 2 GINKGOLIDE-A 1 GINKGOLIDE-B 1 GINKGOLIDES 2 GINSENIN 1 GINSENOSIDES 1 GLABRENE 1 GLABRIDIN 2 GLAZIOVINE 1 GLUCOMANNAN 1 GLUTAMIC-ACID 1 7 Chemical Activity Count GLUTAMINE 1 GLYCYRRHETIC-ACID 1 GLYCYRRHETINIC-ACID 1 GLYCYRRHIZAN-UC 1 GLYCYRRHIZIC-ACID 1 GLYCYRRHIZIN 3 GOSSYPOL 1 GYMNEMIC-ACID 2 HELENALIN 1 HESPERIDIN 1 HINOKITIOL 1 HIRSUTEINE 1 HIRSUTINE 1 HONOKIOL 2 HYPERICIN 2 IBOGAINE 1 INDOLE 1 INOSINE 2 INULIN 2 IRILONE 1 ISOLIQUIRITIGENIN 2 ISOMITRAPHYLLINE 1 ISOPTEROPODINE 1 ISORHYNCHOPHYLLINE 2 JASMONE 1 JESACONITINE 1 KAEMPFEROL 2 8 Chemical Activity Count KALBRECLASINE 1 KAWAIN 1 KHELLIN 1 L-GLUTATHIONE 1 LACTIC-ACID 1 LAPACHOL 1 LAWSONE 1 LENTINAN 1 LIMONENE 1 LINALOOL 1 LINOLEIC-ACID 1 LIQUIRITIGENIN 1 LITHIUM 1 LUTEOLOL 1 LYCORINE 1 LYSOLECITHIN 1 LYSOLECTIN 1 MACROCARPAL-A 1 MACROCARPAL-B 1 MACROCARPAL-C 1 MACROCARPAL-D 1 MACROCARPAL-H 1 MACROCARPAL-I 1 MACROCARPAL-J 1 MAESANINE 1 MAGNESIUM 6 MAGNOLOL 1 9 Chemical Activity Count MALIC-ACID 1 MALTOSE 1 MALVIDIN 1 MANGANESE 1 MANGIFERIN 2 MANGIFERIN-7-O-BETA-GLUCOSIDE 1 MATRINE 1 MEDICARPIN 1 MELATONIN 2 MERREMOSIDE 1 MESACONITINE 1 METHYSTICIN 1 MITRAPHYLLINE 1 MUCILAGE 1 MUCOPOLYSACCHARIDES 1 MYRICETIN 1 MYRISTICIN 1 NABILONE 1 NARINGENIN 1 NEOHERCULIN 1 NEROLIDOL 1 NIACIN 1 NYASOL 1 OBOVATOL 1 OLEANOLIC-ACID 3 OPC 1 OPCS 1 10 Chemical Activity Count OXYMATRINE 1 PAEONIFLORIN 1 PAEONOL 1 PATCHOULI-ALCOHOL 1 PECTIN 2 PHENYLALANINE 1 PHENYLETHYLAMINE 1 PHORBOL 1 PHOSPHORUS 2 PICROTOXININ 1 PILOCARPINE 2 PINITOL 1 PIPEROVATINE 1 PLUMBAGIN 1 POGOSTONE 1 POLYPHENOLS 1 POTASSIUM 2 PROANTHOCYANIDINS 2 PROSTALIDIN-A 1 PROSTALIDIN-B 1 PROSTALIDIN-C 1 PROTOCATECHUIC-ACID 1 PSORALEN 1 PTEROSTILBENE 1 PUERARIN 3 PYCNOGENOL 1 PYRIDOXINE 2 11 Chemical Activity Count QUERCETIN 5 RHAMNOCITRIN 1 RHEIN 2 RICIN 1 ROSMARINIC-ACID 6 RUTIN 2 S-ALLYL-L-CYSTEINE 2 S-METHYL-CYSTEINE-SULFOXIDE 1 SAIKOSAPONIN 2 SANCHINAN-A 1 SANGUINARINE 2 SAPONINS 1 SAPOSHNIKOVAN-A 1 SCHELHAMMERIDINE 1 SELENIUM 4 SEROTONIN 1 SILYMARIN 1 SITOINDOSIDE-IX 1 SITOINDOSIDE-X 1 SITOINDOSIDES 1 SLAFRAMINE 1 SORBITOL 1 SQUALENE 1 SUCROSE 1 SWAINSONINE 1 SWERTIAMARIN 1 SYRINGIN 2 12 Chemical Activity Count TANGERETIN 1 TANNIC-ACID 2 TANNIN 1 TENULIN 1 THAPSIGARGIN 1 THEAFLAVIN-DIGALLATE 1 THIAMIN 1 THYMOL 2 TOCHIBANAN-A 1 TOCHIBANAN-B 1 TOCOPHEROL 4 TOMATINE 1 TRAGACANTH 1 TRICIN 1 TRYPTOPHAN 2 TYLOPHORINE 1 UBIQUINONE 1 UBIQUINONE-Q7 1 UBIQUINONE-Q8 1 UKONAN-A 1 URSOLIC-ACID 3 URUSHIOL 1 VANADIUM 1 VITAMIN-E 3 WITHANOLIDE 1 XANTHONES 1 XYLOSE 1 13 Chemical Activity Count YOHIMBINE 2 ZEXBREVINE 1 ZINC 4 14.
Load more

Recommended publications
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Lyme Disease (Chronic)
    Dr.
    [Show full text]
  • Supporting Materials for Reappointment of Rong Di for 2004
    CURRICULUM VITAE Rong Di Associate Research Professor Department of Plant Biology School of Environmental and Biological Sciences Rutgers University 222B Foran Hall, 59 Dudley Rd., New Brunswick, NJ 08901 Ph. (848)-932-6350, Fax (732)-932-9377 [email protected] http://plantbiology.rutgers.edu/faculty/di/Rong_Di.html July 2017 Appointments 2017-Present Associate Research Professor, Department of Plant Biology, School of Environmental and Biological Sciences, Rutgers University, New Brunswick, NJ 2011-2017 Assistant Research Professor, Department of Plant Biology and Pathology, School of Environmental and Biological Sciences, Rutgers University, New Brunswick, NJ 2014-Present Adjunct Professor, Hainan University, Hainan, China 2003-2011 Assistant Research Professor, Biotechnology Center for Agriculture and the Environment, School of Environmental and Biological Sciences, Rutgers University, New Brunswick, NJ 1997- 2002 Research Associate, Biotechnology Center for Agriculture and the Environment, School of Environmental and Biological Sciences, Rutgers University, New Brunswick, NJ 1992-1996 Postdoctoral Scholar, Dept. of Plant Pathology, and Dept. of Agronomy, University of Kentucky, Lexington, KY 1986-1992 Graduate Research Assistant, Dept. of Plant Pathology, Iowa State University, Ames, IA 1983-1985 Assistant Lecturer, Dept. of Plant Protection, South China College of Tropical Crops (SCCTC), Hainan, P. R. China Education Ph.D. 1992 Plant Virology, Iowa State University, Iowa (Advisor: W Allen Miller) M.S. 1989 Plant Virology, Iowa State University, Iowa (Advisor: John Hill) B.S. 1983 Plant Protection, South China College of Tropical Crops, Hainan, P.R. China Honors and Awards 1985 Selected as the only one among 45 graduates in the Dept. of Plant Protection from SCCTC China to study abroad.
    [Show full text]
  • Medical Botany 6: Active Compounds, Continued- Safety, Regulations
    Medical Botany 6: Active compounds, continued- safety, regulations Anthocyanins / Anthocyanins (Table 5I) O Anthocyanidins (such as malvidin, cyanidin), agrocons of anthocyanins (such as malvidin 3-O- glucoside, cyanidin 3-O-glycoside). O All carry cyanide main structure (aromatic structure). ▪ Introducing or removing the hydroxyl group (-OH) from the structure, The methylation of the structure (-OCH3, methoxyl group), etc. reactants and color materials are shaped. It is commonly found in plants (plant sap). O Flowers, leaves, fruits give their colors (purple, red, red, lilac, blue, purple, pink). O The plant's color is related to the pH of the cell extract. O Red color anthocyanins are blue, blue-purple in alkaline conditions. O Effects of many factors in color As the pH increases, the color becomes blue. the phenyl ring attached to C2; • As the OH number increases, the color becomes blue, • color increases as the methoxyl group increases. O Combination of flavonoids and anthocyanins produces blue shades. There are 6 anthocyanidins, more prevalent among ornamental-red. 3 of them are hydroxylated (delfinine, pelargonidine, cyanidin), 3 are methoxylated (malvidin, peonidin, petunidin). • Orange-colored pelargonidin related. O A hydroxyl group from cyanide contains less. • Lilac, purple, blue color is related to delphinidin. It contains a hydroxyl group more than cyanide. • Three anthocyanidines are common in methyl ether; From these; Peonidine; Cyanide, Malvidin and petunidin; Lt; / RTI & gt; derivative. O They help to pollinize animals for what they are attracted to. Anthocyanins and anthocyanidins are generally anti-inflammatory, cell and tissue protective in mammals. O Catches and removes active oxygen groups (such as O2 * -, HO *) and prevents oxidation.
    [Show full text]
  • What Are Soy Isoflavones? Figure 2: Soy Isoflavones Reduced Plasma Isoprostanes Soy Isoflavones Are a Class of Natural Bioactive Compounds in Soybeans
    TECHNICAL REPORT Purina Veterinary Diets® OM Overweight Management® brand canine dry formula and the Beneficial Role of Isoflavones Introduction Approximately 35% of adult dogs in the U.S. are overweight or obese1. A markedly greater incidence of overweight and obesity was observed in neutered male (59% higher) and female dogs (40% higher)1. Chronic obesity can increase the risk of, or complications from, several chronic diseases including diabetes, hypertension, pulmonary and cardiovascular disease, and degenerative joint disease2. Obesity produces chronic, mild inflammation and increases oxidative stress, which, in turn, contributes to the development of the above-mentioned chronic diseases.3,4 Therefore, reducing obesity and oxidative stress can promote a long life span and improved quality of life in dogs. What are Soy Isoflavones? Figure 2: Soy Isoflavones Reduced Plasma Isoprostanes Soy isoflavones are a class of natural bioactive compounds in soybeans. Natural a Marker of Oxidative Stress soy isoflavones include three chemical compounds: daidzein, genistein, 5 Plasma Isoprostanes (ng/ml) and glycitein. Many health benefits have been associated with regular consumption of soy products. In humans, soy has been found to reduce the 4 risk of cardiovascular disease and certain types of cancer (breast and prostate cancer); relieve a number of problems in post menopausal women including 3 hot flashes, osteoporosis, and decline in cognitive function; reduce cholesterol and triglycerides in plasma; improve symptoms of hypertension; and reduce 2 abdominal fat accumulation.5,6,7 1 Why Did Nestlé Purina 0 Control Isoflavones* Choose Isoflavones? *P<0.01 for Control vs. Isoflavones Soy isoflavones provide a number of benefits for managing dogs with obesity, and reducing rebound effects after weight loss.
    [Show full text]
  • Selective Estrogen Receptor Modulators for BPH: New Factors on the Ground
    Prostate Cancer and Prostatic Disease (2013) 16, 226–232 & 2013 Macmillan Publishers Limited All rights reserved 1365-7852/13 www.nature.com/pcan REVIEW Selective estrogen receptor modulators for BPH: new factors on the ground M Garg1, D Dalela1, D Dalela1, A Goel1, M Kumar1, G Gupta2 and SN Sankhwar1 As the current management of BPH/lower urinary tract symptoms by traditionally involved pharmacological agents such as 5alpha- reductase inhibitors and a1-adrenoceptor antagonists is suboptimal, there is definite need of new therapeutic strategies. There is ample evidence in literature that suggests the role of estrogens in BPH development and management through the different tissue and cell-specific receptors. This article reviews the beneficial actions of selective estrogen receptor modulator (SERM) and ERb- selective ligands, which have been demonstrated through in vitro studies using human prostate cell lines and in vivo animal studies. SERMs have anti-proliferative, anti-inflammatory and pro-apoptotic mechanisms in BPH, and also act by inhibiting various growth factors, and thus represent a unique and novel approach in BPH management directed at estrogen receptors or estrogen metabolism. Prostate Cancer and Prostatic Disease (2013) 16, 226–232; doi:10.1038/pcan.2013.17; published online 18 June 2013 Keywords: selective estrogen receptors modulators; BPH; estradiol; estrogen receptor b INTRODUCTION relevant articles were selected for the discussion of role of SERMs in BPH in BPH is a common urological problem of aging males. It occurs in this review. about 10% of men below the age of 40 and increases to about 80% by 80 years of age.1 Clinical BPH is a benign enlargement of the prostate, which ESTROGENS AND ITS RECEPTORS: ROLE IN BPH results in voiding urinary difficulties that may, sometimes, Though BPH typically manifests in later stage of life when 2 significantly impair the quality of life in older patients.
    [Show full text]
  • Applications of in Silico Methods to Analyze the Toxicity and Estrogen T Receptor-Mediated Properties of Plant-Derived Phytochemicals ∗ K
    Food and Chemical Toxicology 125 (2019) 361–369 Contents lists available at ScienceDirect Food and Chemical Toxicology journal homepage: www.elsevier.com/locate/foodchemtox Applications of in silico methods to analyze the toxicity and estrogen T receptor-mediated properties of plant-derived phytochemicals ∗ K. Kranthi Kumara, P. Yugandharb, B. Uma Devia, T. Siva Kumara, N. Savithrammab, P. Neerajaa, a Department of Zoology, Sri Venkateswara University, Tirupati, 517502, India b Department of Botany, Sri Venkateswara University, Tirupati, 517502, India ARTICLE INFO ABSTRACT Keywords: A myriad of phytochemicals may have potential to lead toxicity and endocrine disruption effects by interfering Phytochemicals with nuclear hormone receptors. In this examination, the toxicity and estrogen receptor−binding abilities of a QSAR modeling set of 2826 phytochemicals were evaluated. The endpoints mutagenicity, carcinogenicity (both CAESAR and ISS Toxicity models), developmental toxicity, skin sensitization and estrogen receptor relative binding affinity (ER_RBA) Nuclear hormone receptor binding were studied using the VEGA QSAR modeling package. Alongside the predictions, models were providing pos- Self−Organizing maps sible information for applicability domains and most similar compounds as similarity sets from their training Clustering and classification schemes sets. This information was subjected to perform the clustering and classification of chemicals using Self−Organizing Maps. The identified clusters and their respective indicators were considered as potential hotspot structures for the specified data set analysis. Molecular screening interpretations of models wereex- hibited accurate predictions. Moreover, the indication sets were defined significant clusters and cluster in- dicators with probable prediction labels (precision). Accordingly, developed QSAR models showed good pre- dictive abilities and robustness, which observed from applicability domains, representation spaces, clustering and classification schemes.
    [Show full text]
  • Anti-Cholinergic Alkaloids As Potential Therapeutic Agents for Alzheimer's Disease
    Indian Journal of Biochemistry & Biophysics Vol. 50, April 2013, pp. 120-125 Anti-cholinergic alkaloids as potential therapeutic agents for Alzheimer’s disease: An in silico approach Huma Naaz, Swati Singh, Veda P Pandey, Priyanka Singh and Upendra N Dwivedi* Bioinformatics Infrastructure Facility, Center of Excellence in Bioinformatics, Department of Biochemistry, University of Lucknow, Lucknow 226 007, India Received 10 September 2012; revised 25 January 2013 Alzheimer’s disease (AD), a progressive neurodegenerative disorder with many cognitive and neuropsychiatric symptoms is biochemically characterized by a significant decrease in the brain neurotransmitter acetylcholine (ACh). Plant-derived metabolites, including alkaloids have been reported to possess neuroprotective properties and are considered to be safe, thus have potential for developing effective therapeutic molecules for neurological disorders, such as AD. Therefore, in the present study, thirteen plant-derived alkaloids, namely pleiocarpine, kopsinine, pleiocarpamine (from Pleiocarpa mutica, family: Annonaceae), oliveroline, noroliveroline, liridonine, isooncodine, polyfothine, darienine (from Polyalthia longifolia, family: Apocynaceae) and eburnamine, eburnamonine, eburnamenine and geissoschizol (from Hunteria zeylanica, family: Apocynaceae) were analyzed for their anti-cholinergic action through docking with acetylcholinesterase (AChE) as target. Among the alkaloids, pleiocarpine showed promising anti-cholinergic potential, while its amino derivative showed about six-fold
    [Show full text]
  • NINDS Custom Collection II
    ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC
    [Show full text]
  • Daidzein and Genistein Content of Cereals
    European Journal of Clinical Nutrition (2002) 56, 961–966 ß 2002 Nature Publishing Group All rights reserved 0954–3007/02 $25.00 www.nature.com/ejcn ORIGINAL COMMUNICATION Daidzein and genistein content of cereals J Liggins1, A Mulligan1,2, S Runswick1 and SA Bingham1,2* 1Medical Research Council Dunn Human Nutrition Unit, Hills Road, Cambridge, UK; and 2European Prospective Investigation of Cancer, University of Cambridge, Cambridge, UK Objective: To analyse 75 cereals and three soy flours commonly eaten in Europe for the phytoestrogens daidzein and genistein. Design: The phytoestrogens daidzein and genistein were extracted from dried foods, and the two isoflavones quantified after hydrolytic removal of any conjugated carbohydrate. Completeness of extraction and any procedural losses of the isoflavones 0 0 were accounted for using synthetic daidzin (7-O-glucosyl-4 -hydroxyisoflavone) and genistin (7-O-glucosyl-4 5-dihydroxyiso- flavone) as internal standards. Setting: Foods from the Cambridge UK area were purchased, prepared for eating, which included cooking if necessary, and freeze dried. Three stock soy flours were also analysed. Results: Eighteen of the foods assayed contained trace or no detectable daidzein or genistein. The soy flours were rich sources, containing 1639 – 2117 mg=kg. The concentration of the two isoflavones in the remaining foods ranged from 33 to 11 873 mg=kg. Conclusion: These analyses will supply useful information to investigators determining the intake of phytoestrogens in cereal products in order to relate intakes to potential biological activities. Sponsorship: This work was supported by the United Kingdom Medical Research Council, Ministry of Agriculture Fisheries and Food (contract FS2034) and the United States of America Army (contract DAMD 17-97-1-7028).
    [Show full text]
  • Mindy Goldman, MD Clinical Professor Dept
    Managing Menopause Medically and Naturally Mindy Goldman, MD Clinical Professor Dept. of Ob/Gyn and Reproductive Sciences Director, Women’s Cancer Care Program, UCSF Breast Care Center and Women’s Health University of California, San Francisco I have nothing to disclose –Mindy Goldman, MD CASE STUDY 50 yr. old G2P2 peri-menopausal woman presents with complaints of significant night sweats interfering with her ability to sleep. She has mild hot flashes during the day. She has never had a bone mineral density test but her mother had a hip fracture at age 62 due to osteoporosis. Her 46 yr. old sister was diagnosed with breast cancer at age 43, treated with lumpectomy and radiation and currently is doing well. There is no other family history of cancer. Questions 1. Would you offer her MHT? 2. If yes, how long would you continue it? 3. If no, what would you offer for alternative treatments? 4. Would your treatment differ if you knew she had underlying heart disease? Is it safe? How long can I take it? What about Mymy Bones?bones? Will it protect my heart? MHT - 2015 What about my brain? Will I get breast cancer? What about my hot flashes? Menopausal Symptoms Hot flashes Night sweats Sleep disturbances Vaginal dryness/Sexual dysfunction Mood disturbances How to Treat Menopausal Symptoms Hormone therapy Alternatives to hormones Complementary and Integrative Techniques Prior to Women’s Health Initiative Hormone therapy primary treatment of menopausal hot flashes Few women would continue hormones past one year By 1990’s well known
    [Show full text]
  • 5994392 Tion of Application No. 67375.734 Eb3-1685, PEN. T
    USOO5994392A United States Patent (19) 11 Patent Number: 5,994,392 Shashoua (45) Date of Patent: Nov.30, 1999 54 ANTIPSYCHOTIC PRODRUGS COMPRISING 5,120,760 6/1992 Horrobin ................................. 514/458 AN ANTIPSYCHOTICAGENT COUPLED TO 5,141,958 8/1992 Crozier-Willi et al. ................ 514/558 AN UNSATURATED FATTY ACID 5,216,023 6/1993 Literati et al. .......................... 514/538 5,246,726 9/1993 Horrobin et al. ....................... 424/646 5,516,800 5/1996 Horrobin et al. ....................... 514/560 75 Inventor: Victor E. Shashoua, Brookline, Mass. 5,580,556 12/1996 Horrobin ................................ 424/85.4 73 Assignee: Neuromedica, Inc., Conshohocken, Pa. FOREIGN PATENT DOCUMENTS 30009 6/1981 European Pat. Off.. 21 Appl. No.: 08/462,820 009 1694 10/1983 European Pat. Off.. 22 Filed: Jun. 5, 1995 09 1694 10/1983 European Pat. Off.. 91694 10/1983 European Pat. Off.. Related U.S. Application Data 59-025327 2/1984 Japan. 1153629 6/1989 Japan. 63 Continuation of application No. 08/080,675, Jun. 21, 1993, 1203331 8/1989 Japan. abandoned, which is a continuation of application No. 07/952,191, Sep. 28, 1992, abandoned, which is a continu- (List continued on next page.) ation of application No. 07/577,329, Sep. 4, 1990, aban doned, which is a continuation-in-part of application No. OTHER PUBLICATIONS 07/535,812,tion of application Jun. 11, No. 1990, 67,375.734 abandoned, Eb3-1685, which is a continu-PEN. T. Higuchi et al. 66 Prodrugs as Noye Drug Delivery Sys 4,933,324, which is a continuation-in-part of application No.
    [Show full text]
  • United States Patent (19) [11] Patent Number: 5,658,584 Yamaguchi 45) Date of Patent: Aug
    US005658584A United States Patent (19) [11] Patent Number: 5,658,584 Yamaguchi 45) Date of Patent: Aug. 19, 1997 54 ANTIMICROBIAL COMPOSITIONS WITH 2-243607 9/1990 Japan ............................. AON 37/10 HNOKTOL AND CTRONELLCACD 4-182408 6/1992 Japan ............................. A01N 6500 5-271073 10/1993 Japan ............................. A61K 31/40 75 Inventor: Yuzo Yamaguchi, Kanagawa, Japan OTHER PUBLICATIONS 73) Assignee: Takasago international Corporation, Tokyo, Japan ROKURO, World Patent Abstract of JP 6048936, Feb. 1994. Osada et al., Patent Abstracts of Japan, JP 3077801, 1991. 21 Appl. No.: 513,181 Osamu Okuda, Koryo Kagaku Soran (Fragrance Chemistry 22 Filed: Aug. 9, 1995 Comprehensive Bibliography) (II), published by Hirokawa Shoten, (1963) p. 1140. (30) Foreign Application Priority Data Yuzo Yamaguchi, Fragrance Journal, No. 46, (1981) Aug. 19, 1994 JP Japan .................................... 6-216686 (Japan) pp. 56-59. (51] Int. Cl. .............. A01N 25/00; A01N 25/06; A01N 25/02; A01N 25/08 Primary Examiner-Edward J. Webman (52) U.S. Cl. ......................... 424/405; 424/404; 424/408; Attorney, Agent, or Firm-Sughrue, Mion, Zinn, Macpeak 424/410; 424/414 & Seas 58 Field of Search ................................. 424/400, 405, 57 ABSTRACT 424/45, 408, 414, 410, 404 An antimicrobial composition containing a mixture of hino 56) References Cited kitiol and citronellic acid in a ratio of about 1:1 to about 3:1 by weight. The antimicrobial composition according to the U.S. PATENT DOCUMENTS invention is safe for humans and has a high antimicrobial 4,645,536 2/1987 Butler ................................... 106/15.05 activity and a broad antimicrobial spectrum, and is widely 5,053,222 10/1991 Takasu et al.
    [Show full text]